The BRCT domain (BRCA1 C-terminal domain) is an important signaling and protein targeting motif in the DNA damage response system. The BRCT domain, which mainly occurs as a singleton (single BRCT) or tandem pair (double BRCT), contains a phosphate-binding pocket that can bind the phosphate from either the DNA end or a phosphopeptide. In this work, we performed a database search, phylogeny reconstruction, and phosphate-binding pocket comparison to analyze the functional evolution of the BRCT domain. We identified new BRCT-containing proteins in bacteria and eukaryotes, and found that the number of BRCT-containing proteins per genome is correlated with genome complexity. Phylogeny analyses revealed that there are two groups of single BRCT domains (sGroup I and sGroup II) and double BRCT domains (dGroup I and dGroup II). These four BRCT groups differ in their phosphatebinding pockets. In eukaryotes, the evolution of the BRCT domain can be divided into three phases. In the first phase, the sGroup I BRCT domain with the phosphate-binding pocket that can bind the phosphate of nicked DNA invaded eukaryotic genome. In the second phase, the phosphate-binding pocket changed from a DNA-binding type to a protein-binding type in sGroup II. The tandem duplication of sGroup II BRCT domain gave birth to double BRCT domain, from which two structurally and functionally distinct groups were evolved. The third phase is after the divergence between animals and plants. Both sGroup I and sGroup II BRCT domains originating in this phase lost the phosphate-binding pocket and many evolved protein-binding sites. Many dGroup I members were evolved in this stage but few dGroup II members were observed. The results further suggested that the BRCT domain expansion and functional change in eukaryote may be driven by the evolution of the DNA damage response system.
Introduction
The DNA damage response is an essential system used by all cellular organisms to detect, signal, and repair DNA damage. 1 The DNA damage response proteins are highly diverse structurally, but many of them contain a conserved globular domain, first identified in BRCA1, the breast cancer tumor suppressor protein, and thus designated BRCT (BRCA1 C-terminus). [2] [3] [4] The BRCT domains can either transmit the signals generated by DNA damage detectors to the repair machinery or target diverse proteins (eg, DNA polymerase λ, DNA ligase III, and DNA ligase IV) into the repair complexes. [5] [6] [7] [8] BRCT domains in some proteins (eg, BRCA1, microcephalin protein MCPH1, and topoisomerase [DNA] II-binding protein, TOPBP1) can also interact directly or indirectly with components of other cell processes, such as cell cycle checkpoint, DNA transcription, DNA replication, and apoptosis. 4, [8] [9] [10] [11] [12] It has been proposed that the BRCT domain may be a link between DNA damage response and other cell processes (eg, cell cycle checkpoint and DNA transcription) which cooperate to repair the damaged DNA. 13 Therefore, it is not surprising that the mutations impairing BRCT domain structures or functions in some proteins, such as BRCA1, may lead to tumors or cancers. 4, 8, 14 The BRCT domain is a folding unit of approximately 95 residues, which consists of a four-stranded parallel β-sheet surrounded by three α-helices (α1, α3-helix on one side and α2-helix on the other side). 2, 5 Previous studies have uncovered two kinds of BRCT modules, ie, a single BRCT such as the C-terminal domain of XRCC1, 5 and a double or tandem pair BRCT in proteins such as BRCA1 and 53BP1. The N-terminal BRCT (BRCTa) and C-terminal BRCT (BRCTb) of double BRCT are closely linked in sequence (about 30 residues) and in three-dimensional structure through the interaction between α2 of BRCTa and α1 and α3 of BRCTb. 9, 14, 15 Both single and double BRCT domains are mainly observed in eukaryote proteins, while the single BRCT domain can also be observed in the NAD + -dependent DNA ligase of bacteria and viruses. 2 The sequence identity between the BRCT domains is very low (average identity approximately 14%), but five conserved hydrophobic motifs are observed, ie, motif A in β1, motif B in α1 and the loop between α1 and β2, motif C in β3, motif D in α3, and motif E at the C-terminal of the BRCT domain. 3 To date, biochemical and cellular studies have shown that BRCT domains can interact in various ways with proteins or DNA. For example, the single BRCT domain in XRCC1 and DNA ligase III can form a heterodimer, which has demonstrated that the BRCT domain can function in protein-protein interactions. 5, 16 The interaction between 53BP1 and p53 suggests that the double BRCT domain can also bind to protein. 9 Yu et al reported that many single and double BRCT domains can bind to phosphopeptides in vitro, and the phosphorylated proteinbinding partners of many double BRCT domains have since been characterized. [6] [7] [8] 17, 18 Williams et al showed that the double BRCT in BRCA1 can bind to a phosphoserine-X-X-phenylalanine (X represents any residue) motif. 19 The phosphoserine is recognized by a phosphate-binding pocket (human BRCA1: serine 1655 and glycine 1656 in the loop between β1 and α1, lysine 1702 at α2) in BRCTa, whereas the phenylalanine is recognized by a hydrophobic pocket at the interface between BRCTa and BRCTb. Interestingly, the single BRCT domains in NAD + -dependent DNA ligase and the replication factor C large subunit, RFC1, also contain a similar phosphate-binding pocket that can bind the phosphate of a DNA nick or end. [20] [21] [22] [23] However, little is known about the processes that have led to these functional divergences. Therefore, we investigated the evolution of the BRCT domain and its functions using the increasing amount of information on crystal structure data and function. Our analyses indicate that the evolution of the eukaryote BRCT domain can be divided into three phases, and that the function is changed from binding DNA to binding protein. This functional change may be influenced by the evolution of the eukaryote DNA damage response interaction network.
Materials and Methods

Data collection
We retrieved 11 BRCT domain-hidden Markov model (HMM) profiles from the Pfam (ftp:// ftp.sanger.ac.uk/pub/databases/Pfam/releases/ Pfam24.0/) and superfamily (http://supfam.org/ SUPERFAMILY/) databases. These profiles were used to search for new BRCT domains against the redundant protein database (NR) using the HMM search program in HMMER. 24 If a new hit was predicted to be a BRCT domain with an E value ,0.001 by any HMM profile, and the hit region did not overlap with another domain in the Pfam database (lower E value) by more than 10 amino acids, PSIPRED 25 was used to predict its secondary structure and ensure that it contained a βαββαβα topological architecture. If not, this new hit was discarded. All members of the new BRCT-containing protein family were retrieved from the NR database using BLASTp, 26 and a HMM profile was built with this new BRCT domain. These new HMM profiles were used to search the NR database with HMM search for the second round. This procedure continued until no new BRCT domain was found. The Mafft program was used for sequence alignment. 27 The default parameters were used for all programs in this procedure, except that the maximum target sequence was set to 10,000 in BLASTp.
Twelve eukaryotic genomes were then searched using the HMM search program with default parameters and 14 HMM profiles which could recognize all the BRCT domains in the NR database. The sequences were aligned using Mafft (Ginsi strategy for S-tree alignment, and Linsi strategy for D-tree and O-tree alignments), 27 and were manually adjusted according to their structures. Columns with more than one-third of gap characters were removed. The linker region between BRCTa and BRCTb in the D-tree alignment was also removed because it was highly diverged between the double BRCT domains. Bayesian trees were reconstructed using Mr Bayes version 3.1 for 200,0000 generations. 28 The likelihood plot and potential scale reduction factor were used to check run convergence. The evolution rate among the sites was set to gamma distribution; the mixed protein substitution model was used, but the WAG model showed 1.0 posterior probability. The maximum-likelihood trees were reconstructed using Treefinder with the WAG model. 29 The expected-likelihood weights test was used to measure the confidence of tree topology with 1000 replications.
Structural conservation analyses
The homologs of each BRCT family were derived in the 12 eukaryotic genomes and the nucleotide NR database held by the National Center for Biotechnological Information. Blastp was used to search the NR database with default parameters. Sequences were listed in Fasta format in the supplementary materials. Sequences of every BRCT family were aligned separately using Mafft with the Linsi strategy and manually edited. Sequence conservation information for each BRCT family was then calculated on the ConSurf server using the maximumlikelihood method, 30 and mapped to their respective Protein Databank structures (Table S2 ) or homology models. The homology models of TOPBP1 BRCT4-5, PTIP BRCT1-2, and PTIP BRCT3-4 were generated using HHpred and Modeller on the Bioinformatics Toolkit website (http://toolkit.tuebingen.mpg.de/sec tions/tertstruct), 31, 32 and multiple Protein Databank structures were automatically selected for templates. DaliLit version 3 was used for structure superimposition using default parameters. 33 The BRCT domain structures, 2EBU and 1T15, were used for RFC1 and BRCA1, respectively, for superimposition of structure.
Results and Discussion
Distribution of the BrcT domain
Database search results showed that BRCT-containing proteins are mainly observed in bacteria and eukaryotes. In bacteria, eight further species-specific single BRCT-containing proteins were identified ( Fig. 1 and Table S1 ), the BRCT domains of which show high sequence identity with that of bacteria NAD + -dependent DNA ligase (average identity approximately 40%). In eukaryotes, new BRCT-containing proteins were also identified, including BRG1-associated factor BAF155, BAF170, ANK-containing protein ANKRD32, and GCN5-related N-acetyltransferase ( Fig. 1 and Fig. S1 ). Because most archaea lineages do not contain BRCT-containing protein, except for the homolog of bacteria NAD + -dependent DNA ligase in some species of euryarchaeotes, these results are consistent with the hypothesis that the eukaryotic BRCT domain may be from bacteria through horizontal gene transfer. 13 The number of BRCT-containing proteins per genome is correlated with genome complexity (one in Escherichia coli, 12 in S. cerevisiae, 27 in H. sapiens, and 28 in O. sativa, see Table S1 ). However, this correlation is not significant between bacteria species, because most have only one or two BRCT-containing proteins, ie, NAD + -dependent DNA ligase and the DNA polymerase III ε subunit. Two explanations can be offered for this correlation in eukaryotes. Firstly, more BRCT-containing proteins have evolved in species with high genome complexity. For example, in A. thaliana and O. sativa, two or more homologs of some animal BRCT-containing proteins, such as CTD phosphatase FCP1, BRCA1 associated RING domain-containing protein BARD1, and TOPBP1, have been identified, and there are also lineage-specific proteins containing 1-4 BRCT domains. In vertebrates, five BRCTcontaining proteins, ie, DNA polymerase µ, terminal deoxynucleotidyl transferase TdT, BAF170, regulatory subunit of Cdc7 kinase DBF4b, and ANKRD32, have evolved. Secondly, some BRCT-containing proteins are less conserved in species with low genome complexity. For example, there are nine single BRCT-containing proteins (RFC1, deoxycytidyl transferase REV1, DNA Pol λ, poly(ADP-ribose) polymerase PARP1, XRCC1, FCP1, TOPBP1, BAF155, and pescadillo protein PES1) and six double BRCT-containing proteins (BRCA1, BARD1, DNA ligase IV, nijmegen breakage syndrome protein NBS1, PAX transcription activation domain interacting protein PTIP, and TOPBP1). These can be observed in many eukaryote lineages, possibly having evolved in a eukaryote ancestor, but some have lost their specific lineage, including PARP1, XRCC1, BRCA1, and BARD1 in S. cerevisiae, and RFC1, DNA polymerase λ, and NBS1 in C. elegans. In addition, C. elegans has 30 BRCT-containing proteins, which is more than that expected according to the correlation. However, 19 of these have a similar domain arrangement of WSN, ANK, and BRCT, suggesting that they may be the result of one gene duplication (Fig. 1) .
Phylogeny of BrcT domains
To examine the evolutionary relationships of the BRCT domains, we performed three phylogenetic analyses with BRCT domains, mainly from nine eukaryote species. The Bayesian and maximumlikelihood methods were used to reconstruct the phylogenetic trees. Twenty single BRCT domains from 17 eukaryote proteins and bacteria NAD The Bayesian S-tree and maximum-likelihood S-tree are consistent in their clustering of single BRCT domains into two major groups (ie, sGroup I and sGroup II) because of the low statistical support between the two groups, although the two trees differ in the placement of some branches within sGroup II. This clustering is further confirmed by sequence analysis. The histidine in motif C and tryptophan in motif D, which locate in the hydrophobic core of the BRCT domain and play important roles in structure stability 5, 34 (Fig. 3A) , are observed in most sGroup II members, but are absent in most sGroup I members (Fig. S4) .
Two double BRCT groups (dGroup I and dGroup II) are observed in the D-tree, with high statistic support (Figs. 2B, S4 and S5). The two groups may share a common origin because TOPBP1 and PTIP contain both dGroup I and dGroup II BRCT domains. Some members of the two groups are distributed across different eukaryote lineages, implying that the two groups are diverged very early.
The O-tree reconstructed by the two methods shows similar topology (Fig. S3) . sGroup II BRCT 
Functional evolution of the BrcT domain
Because the sequence similarity between BRCT domains is low, the phylogenetic analyses may contain noise coming from multiple sequence alignments. Thus, we compared the functional sites between the four BRCT domain groups because their functional sites are more conserved than their sequences. One functional site is the phosphate-binding pocket in both single and double BRCT domains (Figs. 3A-3E ). In this study, we first analyzed the conservation of this pocket in each protein family, and then compared this pocket in the different groups.
In eukaryote RFC1, the phosphate-binding pocket is composed of threonine 415 (or serine) and glycine 416 at the N-terminal of loop 1, arginine 423 at the N-terminal of α1, and lysine 458 at the N-terminal of α2 (Figs. 3A, 3B, and 3C ). Previous studies have revealed that this conserved pocket may bind the phosphate of nicked double-stranded DNA. 20, 21 In bacteria NAD + -dependent ligase, this pocket is also highly conserved, and plays an important role in the formation of the AMP-ligase-DNA complex. 22, 23 Our analyses have demonstrated that this pocket can be observed in the BRCT domain of animal but not plant PARP1, and the threonine 415 is substituted by a hydrophobic residue (human PARP1: leucine 398) which may influence phosphate binding. 19 In PARP3 and PARP4, and telomeric repeat binding factor interacting protein RAP1, two or more residues in this pocket are diverged, implying that these BRCT domains cannot bind nicked double-stranded DNA. Nonetheless, the functional similarity between RFC1 and NAD + -dependent ligase suggests that DNA binding is an important function of the original BRCT fold.
In sGroup II, the phosphate-binding pocket can only be observed in the BRCT domains of XRCC1 AP_DNAJ  HM_53BP1  CK_53BP1  XE_53BP1  TF_53BP1  AA_53BP1  CE_53BP1  SC_RAD9  HM_ANKRD32  CK_ANKRD32   HM_BARD1  CK_BARD1  XE_BARD1  TF_BARD1  NAV_BARD1  AT_BARD1  RI_BARD1   CE_BARD1   AT_BRCA1  RI_BRCA1  MB_BRCA1  TF_BRCA1  HM_BRCA1  CK_BRCA1  NAV_BRCA1  NV_BRCA1  HM_MCPH1_BRCT2-3   CE_MCPH1_BRCT2-3  AT_Nacetyltransferase  RI_Nacetyltransferase  HM_MDC1  XE_MDC1  DA_MDC1 AT_PTIP RI_PTIP CK_PTIP_BRCT5-6 HM_PTIP_BRCT5-6 XE_PTIP_BRCT5-6 TF_PTIP_BRCT5-6 DM_PTIP_BRCT5-6 -8  TF_TOPBP1_BRCT7-8  XE_TOPBP1_BRCT7-8  HM_TOPBP1_BRCT7-8   Ecoli_DNAJ  THETH_DNLJ  DM_RFC1  SC_RFC1  NV_RFC1  XE_RFC1  TF_RFC1  HM_RFC1  CK_RFC1  RI_RFC1  AT_RFC1  CK_PARP1  HM_PARP1  XE_PARP1  TF_PARP1   AT_PARP1  RI_PARP1   CK_RAP1  HM_RAP1  XE_RAP1  TF_RAP1  NV_RAP1  MB_RAP1  IS_RAP1   DM_PARP1   AT_PARP3  RI_PARP3   CK_PARP4  HM_PARP4  TF_PARP4  XE_PARP4  DD_PARP4  TA_PARP4  AT_FCP1  RI_FCP1  CE_FCP1  CK_FCP1  HM_FCP1  XE_FCP1   AT_XRCC1_BRCT1  RI_XRCC1_BRCT1  HM_XRCC1_BRCT1  XE_XRCC1_BRCT1  TF_XRCC1_BRCT1  TC_XRCC1_BRCT1  DD_XRCC1_BRCT1  CE_MCPH1_BRCT1  CK_MCPH1_BRCT1  HM_MCPH1_BRCT1  TF_MCPH1_BRCT1  DM_MCPH1_BRCT1  CK_TOPBP1_BRCT6  HM_TOPBP1_BRCT6  TF_TOPBP1_BRCT6  XE_TOPBP1_BRCT6   DM_TOPBP1_BRCT3  CK_TOPBP1_BRCT3  XE_TOPBP1_BRCT3  HM_TOPBP1_BRCT3  TF_TOPBP1_BRCT3  CE_TOPBP1_BRCT3  CK_BAF155  XE_BAF155  HM_BAF155  TF_BAF155  XE_BAF170  HM_BAF170  TF_BAF170  IS_BAF170  DM_BAP155  NV_BAF170  MB_BAF170  TF_TDT   XE_TDT  HM_TDT  CK_TDT  RI_POLlambda  AT_POLlambda  CK_POLlambda  SK_POLlambda  HM_POLlambda  TF_POLlambda  XE_POLlambda  IS_POLlambda  AT_REV1  RI_REV1  CE_REV1  XE_REV1  CK_REV1  HM_REV1  TF_REV1  DM_REV1  SC_REV1  AT_PES1  RI_PES1  DM_PES1  HM_PES1  XE_PES1  TF_PES1  CE_PES1  SC_PES1  XE_XRCC1_BRCT2  TF_XRCC1_BRCT2  HM_XRCC1_BRCT2  TC_XRCC1_BRCT2 (BRCT1), FCP1, and REV1. However, there are differences between the pockets in these families and that of sGroup I. Arginine 423 is lost in FCP1 and REV1, and threonine 415 is substituted by asparagine in animal REV1 (human REV1: asparagine 57) and aspartate in plant REV1 (A. thaliana REV1: aspartate 96, Fig. S4 ). Nonetheless, other residues in the pocket are highly conserved, suggesting that this pocket is still functional. In addition, other BRCT domains in sGroup II have lost the phosphate-binding pocket and evolved various other protein-binding sites (Fig. 3A) . 5, 34, 35 In all members of dGroup I, the phosphate-binding pocket is observed in BRCTa but not in BRCTb. Unlike single BRCT domains, the main function of this pocket is binding to the phosphate of phosphopeptides (Figs. 3D and 3E) . 6, 7, 12, 19, 28, 36, 37 In order to compare the phosphate-binding pocket between the single and double BRCT domains, we superimposed the BRCT domain of RFC1 and BRCTa of BRCA1 (DaliLite: Z score 8.9, root mean square deviation 3.2). The superimposition showed that threonine 415, glycine 416, and lysine 458 of RFC1 were superimposed well with serine 1655, glycine 1656, and lysine 1702 of BRCA1 (DaliLite relative entropy . 3.456 bit, Fig. 3C ). However, differences are also observed between them. The phosphate-binding pocket in the single BRCT domain contains a highly conserved arginine 423 which is not observed in most BRCTa of dGroup I, and the BRCTa of dGroup I contains conserved threonine/serine (threonine 1700 in BRCA1, Fig. 3C ) that interacts with serine 1655. 19 We therefore named the sGroup I pocket DNA-binding type and dGroup I pocket protein-binding type, but the differences in the phosphate recognition mechanism require further study. Interestingly, both the arginine (arginine 423 in RFC1) and the threonine (threonine 1700 in BRCA1) are conserved in the phosphate-binding pocket of XRCC1 BRCT1 (human XRCC1: arginine 335 and threonine 368), and threonine 1700 is also conserved in the phosphate-binding pocket of the FCP1 BRCT domain (human FCP1: threonine 691). Thus, the phosphate-binding pocket changed from the DNA-binding type to the proteinbinding type in sGroup II, and the pocket in BRCTa may be evolved from that of sGroup II. This hypothesis is supported by the fact that the BRCT domain in FCP1 can bind phosphopeptide. 7 In order to compare the phosphate-binding pocket in dGroup II with that in other groups, we modeled the structure of TOPBP1 BRCT4-5, PTIP BRCT1-2, and PTIP BRCT3-4 using dGroup I BRCT structures as templates (data not shown). The analysis showed that the phosphate binding pocket was observed in BRCTb but not BRCTa of this group except DNA ligase IV. The glycine 146 is substituted by glutamine in TOPBP1 BRCT5 (human TOPBP1: glutamine 655) and PTIP BRCT2 (human PTIP: glutamine 108). Both arginine 423 and threonine 1700 are not observed in this group. Whether these BRCTb domains can bind to phosphate needs further investigation. In DNA ligase IV, the phosphate-binding pocket is only observed in vertebrate BRCTa, the lysine 458 is substituted by arginine (human DNA ligase IV: arginine 708). In addition, our analyses demonstrated that the BRCTa and BRCTb of dGroup II members may not interact through the α2 of BRCTa and α1 and α3 of BRCTb, because the charged residues in the middle of BRCTa α2 (data not shown) cannot interact in a stable manner with the hydrophobic α1 and α3 regions of BRCTb. This was confirmed by a study showing that TOPBP1 BRCT1 and BRCT2, which showed high sequence similarity to the BRCTa and BRCTb of this group, respectively, interact with each other through the linker between BRCT1 and BRCT2, the α2 region of BRCT1, and the C-terminal of BRCT2. 38 Taken together, the intragroup similarity and intergroup differences in the phosphate-binding pocket is consistent with the phylogenetic analyses. In the D-tree, the high statistical support between the two groups may be mainly due to the different interaction patterns between BRCTa and BRCTb.
Evolution of BrcT functions
The DNA-binding function may be conserved in the BRCT domains of bacteria because the DNA-binding pocket residues are conserved in them. However, the functions of eukaryote BRCT domains are diverged. The species distribution, phylogeny, and functional site comparison analyses suggest that evolution of the eukaryote BRCT domain can be divided into three phases. In the first phase, sGroup I members, such as RFC1 and PARP1, obtained the original BRCT fold with the DNA-binding function in the eukaryote ancestor. In the second phase, sGroup II BRCT domains, which contain histidine in motif C and tryptophan in motif D, were evolved. Although the phosphate-binding pocket is retained in XRCC1 (BRCT1), FCP1, and REV1, the functions of single BRCT domains originating in this phase began to diverge, such as the protein-binding function in XRCC1 (BRCT1), REV1, and DNA Pol λ. 5, 34, 35 Double BRCT domains were also evolved in this phase by tandem duplication of the sGroup II BRCT domain containing the phosphate-binding pocket. However, the phosphate-binding pocket was selectively lost in BRCTb of dGroup I and BRCTa of dGroup II. The specific phosphopeptide-binding function may also have evolved in the double BRCT ancestor because phosphopeptide-binding activity has been detected in sGroup II members. 7 The third phase may be after the divergence between animals and plants. Both sGroup I and sGroup II BRCT domains originating in this phase lost the phosphate-binding pocket and many of them evolved protein-binding functions, such as TOPBP1 BRCT6, MCPH1 BRCT1, and XRCC1 BRCT2. 5, 34, 35 Lineage-specific dGroup I members were evolved, but few dGroup II members were observed. In addition to the phosphopeptide-binding function, some dGroup I members have also evolved other protein-binding sites (Fig. 3D) .
In addition, the closely linked structure and high sequence similarities between the N-terminal three BRCT domains of TOPBP1 and ECT2 (identities: BRCT0 23%, BRCT1 40%, and BRCT2 30%) suggest that the BRCT domain may have evolved with three BRCT domains as a unit. This is supported by a recent crystal structure and function study of TOPBP1 BRCT0-2.38. The central β-sheets in the three BRCT domains are perpendicular to each other rather than parallel as in dGroup I BRCT structures. The phosphate-binding pocket is conserved in ECT2 BRCT1, TOPBP1 BRCT1, and BRCT2, but arginine 423 and threonine 1700 are not observed in these pockets. TOPBP1 BRCT1 can bind phosphoserine 387 of RAD9. 38 Furthermore, there are reports that multiple BRCT domains function together, such as the phosphorylation-dependent interaction between PTIP3-6 and 53BP1. 39 Thus, there are other functional and evolutionary modules with multiple BRCT domains which may link multiple proteins together.
Evolution of eukaryote BrcT domain in DnA damage response
Because most eukaryote BRCT domains function as signaling and protein targeting motifs in the DNA damage response system, [2] [3] [4] 8, 18 the question arises as to how the BRCT domain evolved in this system. Because the evolution of the DNA damage response system is affected by pressures from both the external and internal environments, such as lifestyle and genome complexity, the components of this system may be coevolved under these pressures. 13 The DNA repair functions of eukaryote proteins that contain the first-phase and second-phase BRCT domains, such as RFC1, PARP1, REV1, and XRCC 1, 20, 35, 40, 41 suggest that the BRCT domain may function firstly in the DNA repair process. This can be explained by the fact that in the early stage of evolution of the eukaryote DNA repair process, the DNA repair proteins may be targeted to the exact site of damage independently because no sophisticated protein interaction network had evolved. Thus, the DNA end or nick binding function of the BRCT domain may be essential for these proteins. However, as the protein interaction network became more sophisticated, especially after the divergence of the metazoan/fungi group from plants, more proteins were targeted to sites of DNA damage by protein complexes which are more rapid and more efficient than targeted independently by DNA end-binding motifs. 42 Thus, the protein-binding function is more necessary than the DNA end-targeting function. This may explain why the single BRCT domains originating in the third phase changed their function from binding DNA to binding protein.
In the second phase of BRCT domain evolution, the specific phosphomotif-binding function of the double BRCT domain, which can recognize phosphomotifs generated by DNA damage detectors, 6, 7, 10, 36, 37 such as ATR and ATM, extends the BRCT domain to DNA damage signaling. The double BRCT domain then expands in DNA damage-signaling proteins accompanying changes in the internal environment. For example, the higher order chromatin structure formed by histones and DNA create barriers to DNA damage signaling and recruitment of repair enzymes for damaged DNA; the rise of multicellularity may have led to expression of tissue-specific genes in response to DNA damage. 13 Therefore, more proteins and signaling motifs may be required to communicate between components of the DNA damage system or with other cellular processes. The expansion of the BRCT domain, especially dGroup I members, may partially satisfy these requirements.
Taken together, the evolution of the eukaryote BRCT domain may be influenced by the evolution of the DNA damage response system. In organisms living in complex environments, for which a highly efficient DNA damage response system is essential, more BRCT domains may be required to recruit proteins to the damage sites and for signaling between cell processes, which may explain the correlation between BRCT domain number and genome complexity. 
